
Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 07, 2025, titled "Press release regarding change in name of the Company".
Filed with NSE ·

Suven Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 07, 2025, titled "Press release regarding change in name of the Company".
6ix hasn’t read this filing yet.
Cohance Lifesciences Ltd on 6ix
Follow Cohance Lifesciences into a list and get an email when it puts out news.
Follow Cohance Lifesciences